Role of epigenetic regulators in Single Base Substitution patterns in AML
STAG2-mutated AML patients: ASXL1 cohesin binding motif status and mutation landscape
BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
Exploitation of treatment induced tumor lysis to enhance sensitivity of ctDNA analysis: A first-in-human pilot study
Alignment of TMB measured on clinical samples: Phase IIB of the Friends of Cancer Research TMB Harmonization Project
Different genomic mutations signatures are associated to specific PD-L1/TMB states on lung cancer with potential value for patients screening for immunotherapy
A comprehensive genomic profiling approach to interrogate hematologic malignancies
Analytical development of the RaDaRTM assay, a highly sensitive and specific assay for the monitoring of minimal residual disease